Compare Illinois Tool Works Inc. (ITW) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illinois Tool Works Inc. vs Pfizer Inc — how do they compare? Illinois Tool Works Inc. trades at $272.11 (market cap $79.42B), while Pfizer Inc trades at $24.89 (market cap $142.77B). The key difference: Pfizer Inc is the larger of the two by market cap, and Pfizer Inc pays the higher dividend (6.87%). Which is the better fit depends on your goals.
| ITW | PFE | |
|---|---|---|
Market Cap | $79.42B | $142.77B |
Sector | Industrials | Health |
52-Week High | $299.60 | $28.56 |
52-Week Low | $241.07 | $23.29 |
Enterprise Value | $87.74B | $193.43B |
Dividend Yield | 2.33% | 6.87% |
Volume | — | 29,869,932 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illinois Tool Works (ITW) trades at $276.05, down 2.45% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company maintains strong profitability with a 19.32% net income margin and has beaten earnings estimates for the last three quarters. Recent news highlights mixed sentiment, with some analysts citing premium valuation concerns while others note growth prospects from enterprise initiatives.
The outlook is cautiously optimistic, supported by consistent earnings beats and a solid dividend, but risks include high valuation multiples and exposure to construction sector weakness. The consensus price target of $288.25 suggests modest upside potential from current levels.
Pfizer (PFE) trades at $25.05, down 0.36% on the day, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company maintains strong profitability with 73.51% gross margins and has beaten earnings estimates for three consecutive quarters. Recent news highlights Pfizer's focus on obesity and oncology pipeline development as key growth drivers for 2026.
The stock presents a value opportunity with a P/E of 19.12 below industry averages, supported by consistent dividend payments. However, patent cliff concerns and revenue normalization post-COVID remain headwinds. Analyst consensus leans toward Hold with a $28.25 price target, suggesting modest upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
